Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 21, 2016
Dalton Pharma Services has entered into a contract service agreement with the United States Army Medical Materiel Development Activity (USAMMDA) in support of the US Army’s product development program for the treatment of severe or complicated ...
read more
Tuesday, December 20, 2016
PROTAGEN AG, a provider of pharma development services, novel diagnostic tests and companion diagnostics in the fields of immuno-oncology and autoimmune disease, today has announced the successful completion a collaboration agreement with Novartis ...
read more
Tuesday, December 20, 2016
Novasep, a supplier of services and technologies for the life sciences industry, has announced that three of its custom manufacturing sites individually passed the general inspection process of the US Food and Drug Administration (FDA) free of any ...
read more
Tuesday, December 20, 2016
Oxford Genetics Ltd, a biotech company that which specializes in DNA design, protein and viral expression systems, and cell line engineering, has secured a £1.61 million grant from Innovate UK. The funding will support a new research project ...
read more
Monday, December 19, 2016
Catalyst Biosciences has secured all rights to the manufacturing process for marzeptacog alfa (activated) (formerly known as CB 813d) from Wyeth LLC, a wholly-owned subsidiary of Pfizer. Marzeptacog alfa (activated) is a next-generation Factor VIIa ...
read more
Monday, December 19, 2016
ERT, a l provider of high-quality patient data collection solutions for use in clinical drug development, has announced the acquisition of Exco InTouch, a provider of patient engagement, data capture and digital health solutions. The combined ...
read more
Monday, December 19, 2016
bluebird bio and apceth Biopharma GmbH have entered into a strategic manufacturing agreement providing for the future European commercial production of bluebird bio’s Lenti-D™ product candidate for cerebral adrenoleukodystropy and its LentiGlobin™ ...
read more
Monday, December 19, 2016
Catalent Pharma Solutions has signed an agreement with PATH, an international nonprofit organization and a leader in global health innovation, to advance a project funded by its Malaria Vaccine Initiative (MVI).
read more
Monday, December 19, 2016
Participate in the bio-industry's most in-depth, global benchmarking and analysis study: 14th Annual Biopharmaceutical Manufacturing Report and Survey.
read more
Monday, December 19, 2016
DuPont Industrial Biosciences today announced receipt of a grant from the Bill & Melinda Gates Foundation to support a new area of research. The research project, which commences immediately, aims to create new production systems to enable affordable...
read more
Monday, December 19, 2016
Pharma Tech Industries has introduced a new high-speed bottling line for the production of Rx, OTC and nutritional ingestible products at its Union, MO facility.
read more
Wednesday, December 14, 2016
ConverGene has entered into an exclusive license agreement with the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health. Under this agreement, ConverGene has the rights to commercialize jointly ...
read more
Wednesday, December 14, 2016
Recipharm has appointed Anders Högdin and Aaron Small to lead the growth of its pharmaceutical development services business in the US and Europe.
read more
Wednesday, December 14, 2016
PROTAGEN AG, a provider of pharma development services, companion diagnostics and novel diagnostic tests in the fields of immuno-oncology and autoimmune disease, has announced the launch of NavigAID SSc, a disease stratification assay designed to ...
read more
Wednesday, December 14, 2016
Whitehouse Laboratories, a division of AMRI, announced the addition of Disinfectant Efficacy testing capability to its Microbiology Laboratory. Clients will now have the opportunity to test their disinfectants for effectiveness based on AOAC and USP ...
read more